Fred Cohen

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.

Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada.

Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA.

CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA.

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C.

Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA

Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.

Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA.

ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy.

Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL.

Sorrento Tech, Inc., also known as Roka Bio Science, is a private company that specializes in food safety technology. The company is based in Warren, NJ and has subsidiaries in the United States. The company's core technology is the Roka pathogen detection assays, which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to deliver a fully automated, single-protocol assay with reduced enrichment times and superior sensitivity. The company's products include the Atlas® system and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bio Science provides solutions for the beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing industries. Roka Bio Science was founded in 2009 by Paul G. Thomas.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo.

Part of Cognex Corp., Acumen, Inc. is an American company that develops machine vision systems. The private company is based in OR. Acumen was acquired by Cognex Corp. from ATS Corp. on July 27, 1995 for $14 million.

Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India.

The Plastics Group, Inc. designs and manufactures custom blow-molded and rotational-molded plastic parts. The firm's products include fuel systems, seating systems, material solutions and air and fluid systems. The company was founded in 1997 and is headquartered in Willowbrook, IL.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

The UCSF Foundation promotes and supports the interests and welfare of the University of California San Francisco and the UCSF Medical Center. The UCSF Foundation’s daily operations are administered by a development staff responsible for major gifts, planned giving, corporate and foundation gifts, annual giving, development communications, alumni relations and campus events

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI.

CHV Capital, Inc.(CHV Capital) is a venture Capital firm founded in 2007 by Kyle J. Salyers. The firm is headquartered in Indianapolis.

Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia.

Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ.

Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA.

Precision Medicine Group LLC engages in the provision of an integrated infrastructure that supports pharmaceutical and life sciences companies. It offers translational informatics and biometrics, specialty lab, biomaterials, oncology, and diagnostics and medical device solutions. The company was founded by Ethan D. Leder and Mark P. Clein in 2012 and is headquartered in Bethesda, MD.

Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA.

Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements.

VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts.

Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia.

The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee.

Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore.

Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015.

Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation.

HIBio, Inc. is a clinical immunology company that leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases. The company is based in South San Francisco, CA. HIBio is excited to work as part of a collaborative team. HIBio was founded by Tim Behrens and Travis Murdoch, with Travis Murdoch serving as the CEO since incorporation.

Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB.